Overview

Gender

male

Dr. Hoey is chief scientific officer at Tenaya Therapeutics, where he is responsible for directing research to develop novel agents for treating heart disease. Prior to Tenaya, he directed preclinical research and drug development as senior vice president and co-chief scientific officer at OncoMed Pharmaceuticals. Dr. Hoey previously served as biology director at Amgen (formerly Tularik) in San Francisco. He conducted postdoctoral training at the University of California, Berkeley under Dr. Robert Tjian and completed his graduate work at Columbia University with Dr. Michael Levine. Dr. Hoey is an inventor on numerous patents and co-author of over 70 peer-reviewed publications.